Herborium® Group Recent Social Marketing Campaign Grows Cyber Monday Sales 27% Healing Power of Botanical Therapeutics®
SADDLE BROOK, N.J., Dec. 7, 2011 /PRNewswire/ -- Herborium Group, Inc., (PK: HBRM) is pleased to announce that its recently launched social media marketing campaign for its acne treatment, AcnEase®, is already producing positive results. Cyber Monday sales for AcnEase, the Company's flagship all botanical acne treatment, grew 27% as compared to 2010. The Company contributes this growth to the efforts being employed in the social media space to bring AcnEase to the consumers worldwide. Initial activities have included an updated FaceBook and Twitter presence, a new blog and third party representations in the beauty industry.
"We believe that this most satisfying increase in sales of AcnEase is just the beginning of the impact our strategies will have on sales. The extremely positive consumer response to the initial phase of our social media strategy is a strong indicator of future growth in revenues," commented Dr. Agnes P. Olszewski, President and CEO of Herborium.
"AcnEase is an all botanical ingredients based product that has proven effective for eliminating acne in both teenagers and adults of all ethnic groups with consumers with all skin types and colors benefiting from the results. AcnEase is safe and effective and can be used by both women and men without irritating, bleaching or discoloring the skin. As a result of this broad beneficial characteristics of AcnEase, Herborium has undertaken a number of initiatives to reach different –so far untapped ethnic markets of acne sufferers in the US and Europe. Our focus ending 2011 and going into 2012 will be on bringing those initiatives to fruition in terms of revenues," concluded Dr. Olszewski
About The $50 Billion Acne Market
Over 130 million individuals of all ethnic backgrounds are currently diagnosed with Acne in the USA and Europe alone with the $50 billion in revenues generated in acne treatments worldwide. For the past decade there is a steady growth in a total number of individuals suffering from acne and in sales acne treatments. New market needs are also emerging in this sector. Three most important of those trends became a special focus of Herborium marketing strategy: Increase in incidents of Adult Acne (over 17 million adults in the USA have acne) while most of acne treatments focus on teenagers; a growing demand for acne treatment suitable for all ethnic groups (while the supply of efficacious, targeted products in this category is almost non-existent); and the demand for truly natural and treatment that can provide satisfactory results.
About AcnEase (www.acnease.com)
AcnEase® is a proprietary, all herbal, systemically acting botanical therapeutic® targeting the symptoms of acne in both females and males of all ages. Unlike many herbal products, AcnEase has been validated through clinical testing. The results demonstrated that approximately 95% of the patients with adolescent acne responded positively to AcnEase. In adults with hormonal or chronic acne the level of effectiveness was 85%. The overall positive response rate to AcnEase was 91%. To date, after 5 plus years on the market, Herborium has registered a 95.5% consumer satisfaction rate for the AcnEase product.
About Herborium Group, Inc. (www.herborium.com)
Herborium Group, Inc., a botanical therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. The company secured a pipeline of botanical ingredients based products in the areas of Dermatology, Prostate Health (BPH), Liver Diseases and Women's and Men's Health and selected sexual disorders. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.
One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission
For more information please inquire: DrAgnes@Herborium.com
SOURCE Herborium Group, Inc.